Cite
HARVARD Citation
Murray, L. et al. (2016). Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort. Clinical oncology. 28 (1), pp. 4-12. [Online].